S1YK34 Stock Overview
Operates as a medical technology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Stryker Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$109.62 |
| 52 Week High | US$120.24 |
| 52 Week Low | US$70.28 |
| Beta | 0.95 |
| 1 Month Change | -2.68% |
| 3 Month Change | 7.37% |
| 1 Year Change | 53.83% |
| 3 Year Change | 56.00% |
| 5 Year Change | n/a |
| Change since IPO | 141.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| S1YK34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -3.6% | -1.6% | -3.1% |
| 1Y | 53.8% | 7.2% | -11.4% |
Return vs Industry: S1YK34 exceeded the BR Medical Equipment industry which returned 6.6% over the past year.
Return vs Market: S1YK34 exceeded the BR Market which returned -11.4% over the past year.
Price Volatility
| S1YK34 volatility | |
|---|---|
| S1YK34 Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in BR Market | 9.5% |
| 10% least volatile stocks in BR Market | 2.8% |
Stable Share Price: S1YK34 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: S1YK34's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 52,000 | Kevin Lobo | www.stryker.com |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Stryker Corporation Fundamentals Summary
| S1YK34 fundamental statistics | |
|---|---|
| Market cap | R$845.73b |
| Earnings (TTM) | R$21.84b |
| Revenue (TTM) | R$133.71b |
38.7x
P/E Ratio6.3x
P/S RatioIs S1YK34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S1YK34 income statement (TTM) | |
|---|---|
| Revenue | US$21.97b |
| Cost of Revenue | US$7.92b |
| Gross Profit | US$14.06b |
| Other Expenses | US$10.47b |
| Earnings | US$3.59b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.42 |
| Gross Margin | 63.97% |
| Net Profit Margin | 16.34% |
| Debt/Equity Ratio | 76.8% |
How did S1YK34 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield34%
Payout RatioDoes S1YK34 pay a reliable dividends?
See S1YK34 dividend history and benchmarks| Stryker dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Feb 06 2025 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 46 days |
Does S1YK34 pay a reliable dividends?
See S1YK34 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:58 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Stryker Corporation is covered by 72 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Richard Purkiss | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |